IP Library Granted Patent US 8,206,911
Granted Patent B2
US 8,206,911 · App. 12/715,082 · Granted Jun 26, 2012

Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same

Assignee: Cornell Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,206,911
App. No.
12/715,082
Granted
Jun 26, 2012
Kind
B2
Abstract

Tools and methods are provided for determining whether or not a dog is genetically normal, is a carrier of, or is affected with or predisposed to progressive rod-cone degeneration. The method is based on the detection of a transversion from G to A at position corresponding to nucleotide position 1298 of SEQ ID NO: 1.

Claims (17)

1. A method for identifying a dog as genetically normal, as a carrier of, or as affected with or predisposed to progressive rod cone degeneration comprising:

a) providing a biological sample obtained from the dog, said biological sample comprising nucleic acids; and

b) detecting in the biological sample whether or not there is a change from G to A at position 1298 in SEQ ID NO:1, identifying the dog to be a carrier of progressive rod cone degeneration, affected with or predisposed to progressive rod cone degeneration, or normal, wherein the G to A change in one allele is indicative of a carrier of progressive rod-cone degeneration, the G to A change in both alleles is indicative of a dog affected with or predisposed to progressive rod-cone degeneration, and the absence of the G to A change is indicative of a genetically normal dog.

2. The method of claim 1 , wherein the nucleic acid is DNA.

3. The method of claim 1 , wherein the nucleic acid is mRNA.

4. The method of claim 1 , wherein the biological sample is any tissue containing genomic DNA or mRNA.

5. The method of claim 1 , wherein the biological sample is selected from the group consisting of blood, hair, mucosal scrapings, semen, tissue biopsy and saliva.

6. The method of claim 1 , wherein the biological sample is saliva.

7. A method for identifying a dog as genetically normal, as a carrier of, or as affected with or predisposed to progressive rod cone degeneration comprising:

a) providing a biological sample obtained from the dog, said biological sample comprising nucleic acids;

b) detecting in the biological sample whether or not there is a change from G to A at position 1298 in SEQ ID NO:1;

c) based on the detecting in b), identifying the dog to be a carrier of progressive rod cone degeneration, affected with or predisposed to progressive rod cone degeneration, or normal, wherein the G to A change in one allele is indicative of a carrier of progressive rod-cone degeneration, the G to A change in both alleles is indicative of a dog affected with or predisposed to progressive rod-cone degeneration, and the absence of the G to A change is indicative of a genetically normal dog.

8. The method of claim 7 , wherein the nucleic acid is DNA.

9. The method of claim 7 , wherein the nucleic acid is mRNA.

10. The method of claim 7 , wherein the biological sample is any tissue containing genomic DNA or mRNA.

11. The method of claim 10 , wherein the biological sample is selected from the group consisting of blood, hair, mucosal scrapings, semen, tissue biopsy and saliva.

12. The method of claim 11 , wherein the biological sample is saliva.

Assignments (1)
CONFIRMATORY LICENSE Recorded Apr 12, 2011
From: CORNELL UNIVERSITY / CORNELL RESEARCH FOUNDATION, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026108/0680 →
Continuity (4)
Continuation 11983870 · Nov 13, 2007
Division 11157743 · Jun 21, 2005
Provisional Application 60581499 · Jun 21, 2004
Related Publication 20100323349A1 · Dec 23, 2010